International Association for the Study of Lung Cancer

International Association for the Study of Lung Cancer Bookmark us: http://www.iaslc.org/ or Follow us on Twitter:

Dr. Jie Wang shared results from the first-of-its-kind ACROSS 2 trial comparing aumolertinib monotherapy and combination...
09/28/2025

Dr. Jie Wang shared results from the first-of-its-kind ACROSS 2 trial comparing aumolertinib monotherapy and combination therapy in patients with both EGFR mutations and TSGs. 🧬

Learn more in ILCN: https://bit.ly/4pHvBqk

For , we’re revisiting a powerful past episode of our Lung Cancer Considered podcast.In “Global Advances and Persiste...
09/25/2025

For , we’re revisiting a powerful past episode of our Lung Cancer Considered podcast.

In “Global Advances and Persistent Disparities in Lung Cancer Treatment,” Dr. Narjust Florez, Dr. Csaba Dégi, and Jill Feldman discuss:
✅ Breakthroughs transforming lung cancer care worldwide
✅ The disparities that still leave too many behind
✅ The need for equity-driven action

Listen below ⬇️

In this episode of Lung Cancer Considered, host Dr. Narjust Florez moderates a discussion with Dr. Csaba Dégi and Jill Feldman about global policy. The discuss ...

Could ivonescimab plus chemo be a promising post-TKI option in EGFR-mutant NSCLC? 🤔Dr. Jonathan W. Goldman demonstrated ...
09/25/2025

Could ivonescimab plus chemo be a promising post-TKI option in EGFR-mutant NSCLC? 🤔

Dr. Jonathan W. Goldman demonstrated that adding ivonescimab to chemotherapy improved PFS in patients with EGFR+ NSCLC after third-generation EGFR-TKI therapy.

🔗 Read the highlights in ILCN: https://www.ilcn.org/ivonescimab-chemotherapy-combo-shows-promise-as-post-tki-option-in-egfr-mutant-nsclc/?utm_source=facebook&utm_medium=social&utm_campaign=IASLC-WCLC-2025-Post1-assoc-facebook-share&utm_content=link-share

- Relive the top moments from and share your memories in the Photo Gallery!View now in ILCN: https://bit.ly/4nz6jsz
09/25/2025

- Relive the top moments from and share your memories in the Photo Gallery!
View now in ILCN: https://bit.ly/4nz6jsz

Have you saved your spot yet? 🚨The 2025 Hot Topic in Basic and Translational Science Meeting is just around the corner, ...
09/22/2025

Have you saved your spot yet? 🚨

The 2025 Hot Topic in Basic and Translational Science Meeting is just around the corner, and we’re bringing together an incredible lineup of faculty you won’t want to miss.
- Explore groundbreaking science.
- Connect with leaders in the field.
- Be part of the conversation shaping the future.

Learn more about our faculty and register today: http://bit.ly/48epcNd

Out now! A new episode of Lung Cancer Considered (in Hebrew). Host Dr. Alona Zer sits down with Dr. Haitam Nasrallah, Dr...
09/19/2025

Out now! A new episode of Lung Cancer Considered (in Hebrew). Host Dr. Alona Zer sits down with Dr. Haitam Nasrallah, Dr. Jair Bar, and Dr. Ory Wiesel to share their key takeaways from the 2025 World Conference on Lung Cancer.

From the latest clinical advances to big-picture research trends, don’t miss this engaging conversation.

🎧 Listen here: https://bit.ly/48l1M8E

🔬 Investigators shared results from mono, combination studies of iza-bren with attendees in Barcelona. 🔗 Learn more de...
09/19/2025

🔬 Investigators shared results from mono, combination studies of iza-bren with attendees in Barcelona.
🔗 Learn more details in ILCN: https://bit.ly/4n8GuQk

Investigators Wenfeng Fang, MD, PhD, and Fei Zhou, MD, PhD, share results from mono, combination studies of iza-bren. The data will be discussed during an oral abstract session Monday afternoon.

Recap: Dr. Mary Pasquinelli said the Sybil AI model shows promise for improving early detection and addressing dispari...
09/17/2025

Recap: Dr. Mary Pasquinelli said the Sybil AI model shows promise for improving early detection and addressing disparities in lung cancer outcomes.
🔗 Learn more in ILCN: https://bit.ly/46844qf

Dr. Mary Pasquinelli said that Sybil shows promise for improving early detection and addressing disparities in lung cancer outcomes.

🚨 New Lung Cancer Considered podcast episode, recorded at !Hosts Dr. Narjust Florez and Dr. Stephen Liu take you inside...
09/17/2025

🚨 New Lung Cancer Considered podcast episode, recorded at !
Hosts Dr. Narjust Florez and Dr. Stephen Liu take you inside the biggest conference moments with expert insights from:
🧬 Dr. Susan Scott on EGFR-mutant NSCLC and PALOMA-2
💉 Dr. Wenfeng Fang on a first-in-class EGFR x HER3 ADC
🧠 Dr. Biagio Ricciuti on FLAURA-2 OS, the HARMONi trial & early-stage immunotherapy
Catch the full episode: https://bit.ly/462HfEx

The spirit of WCLC 2025 lives on!Thank you to everyone who joined us for four days of learning and connection. Here’s a ...
09/16/2025

The spirit of WCLC 2025 lives on!
Thank you to everyone who joined us for four days of learning and connection. Here’s a look back at the conference that brought our community together!
Don’t forget to follow our Instagram () and Linkedin (/iaslc) page for more pictures!

Couldn’t attend in Barcelona? 🌍Get the most important updates in just one webinar: The Best of WCLC 2025 on September ...
09/15/2025

Couldn’t attend in Barcelona? 🌍
Get the most important updates in just one webinar: The Best of WCLC 2025 on September 18.

📅 September 18 | 6 AM (MT) | 10 AM (UTC)
👩‍⚕️ Moderators: Dr. Clarissa Baldotto & Dr. Calvin Ng
🎓 CME, MOC, and Certificate of Attendance available
Register now! https://bit.ly/4n5YPxu

09/14/2025

🚨 Final Call! Abstract submissions for HT25: Unraveling Precancer & Early-Stage Lung Cancer close September 15.

🎥 Conference Co-Chair Aaron Tan shares why your research belongs at this year’s Hot Topic Meeting in Tokyo.

Don’t miss your chance to showcase your work at this premier event.
Submit today: https://www.fallht-iaslc.org/

Address

1775 N. Sherman Street, Suite 1600
Denver, CO
80203

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18554642752

Website

http://www.twitter.com/iaslc

Alerts

Be the first to know and let us send you an email when International Association for the Study of Lung Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to International Association for the Study of Lung Cancer:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is on a mission to conquer thoracic cancers worldwide. Through hosting global conferences, funding cutting-edge research and educating the health care community and the general public on all aspects of thoracic cancers, the IASLC strives to alleviate the burden lung cancer places on patients, families and communities.

Each year, the IASLC hosts the World Conference on Lung Cancer (WCLC), the world’s largest meeting dedicated solely to thoracic cancers. The WCLC regularly attracts over 7,000 thoracic cancer specialists from over 100 countries and offers attendees the chance to collaborate and network while learning about the latest updates in the field.

The IASLC Foundation supports the education of research fellows - who are the next generation of lung cancer physicians and scientists - by funding research fellowships. Since its inception, the foundation has given nearly $3.5 million to lung cancer research, and that number is on the rise.

Additionally, the IASLC publishes the Journal of Thoracic Oncology (JTO), a primary source for educational information related to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Over its publication history, the JTO has established itself as an authoritative resource in the field, and the journal recently saw its impact factor increase from 6.595 in 2016 to 10.336 in 2017.